Experimental and Clinical Psychopharmacology · 1998 · 108 citations · 33 references
MedicineBehavioral SciencesPharmacologyBehavioral PharmacologyNeuropharmacologyPsychopharmacologyDrug DiscriminationPsychostimulant PharmacologyStimulant PharmacologyStimulant PharmacotherapyStimulant TherapyAcute Stimulant EffectsAmphetamine DerivativesBehavioral Pharmacology AssaysMethylphenidate PharmacologyMethylphenidate TherapyStimulant ActionStimulant Discrimination
The discriminative-stimulus and participate-rated effects of a range of doses of d-amphetamine (2.5-20 mg), methylphenidate (5-40 mg), bupropion (50-400 mg), and triazolam (0.0625-0.5 mg) were tested in 5 humans trained to discriminate between oral d-amphetamine (20 mg) and placebo. d-Amphetamine and methylphenidate generally dose dependently increased drug-appropriate responding. Bupropion and triazolam on average occasioned less than or equal to 40% drug-appropriate responding. d-Amphetamine, methylphenidate, and bupropion produced stimulant-like participant-rated effects, while triazolam produced sedative-like effects. These results further demonstrate that the acute behavioral effects of d-amphetamine and methylphenidate overlap extensively in humans, which is concordant with preclinical studies. Bupropion produced some d-amphetamine-like, participant-rated drug effects but did not occasion significant levels of d-amphetamine-appropriate responding. These findings are concordant with previous findings of a dissociation between the discriminative-stimulus and participant-rated effects of drugs.
33
Goodman and Gilman's the Pharmacological Basis of Therapeutics
William H. Stigelman, D Pharm · Military Medicine · 1986 · 6.8K citations
Douglas M. McNair · Medical Entomology and Zoology · 1992 · 2.5K citations
A Survey of Medication Treatment for Hyperactive/Inattentive Students
Daniel J. Safer · JAMA · 1988 · 274 citations